|
FDA issues warning about use of high total base content hemodialysis solutions. |
 |
 |
|
FDA: Health care providers should review the dialysate acid concentrate labeling for the specific concentrate that they prescribe to determine the components that can contribute to the patient’s overall bicarbonate levels. The levels of acetate, citrate and/or acetic acid vary by formulation and by manufacturer. Be aware that metabolic alkalosis (pre-dialysis serum bicarbonate levels > or = to 27 mEq/L) has been associated with a higher risk of death in hemodialysis patients.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
